Atomic AI develops RNA-centric medicines using a platform that combines machine learning with structural biology for drug discovery.
Atomic AI is a biotechnology company focused on drug discovery, specifically in the realm of RNA-centric medicines. The company integrates machine learning with structural biology to develop new therapeutics, including RNA-targeted small molecules and RNA-based treatments. Their core technology is the ATOM-1 foundation model, which is designed to predict the three-dimensional structure of RNA with high precision. The company's R&D platform utilizes deep learning models in conjunction with in-house wet-lab assays. This integrated approach aims to identify and develop new drug targets that were previously inaccessible, thereby advancing the field of RNA drug discovery.
Platforms: Web
View full Atomic AI profile on Tools-Radar | Browse Healthcare tools | Alternatives to Atomic AI
Tools-Radar is a free directory of 10,000+ AI tools — discover, compare, and choose the right AI software for your needs. Visit tools-radar.com